↓ Skip to main content

Rituximab for Children with Immune Thrombocytopenia: A Systematic Review

Overview of attention for article published in PLOS ONE, May 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

policy
2 policy sources
twitter
1 X user

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rituximab for Children with Immune Thrombocytopenia: A Systematic Review
Published in
PLOS ONE, May 2012
DOI 10.1371/journal.pone.0036698
Pubmed ID
Authors

Yi Liang, Lingli Zhang, Ju Gao, Die Hu, Yuan Ai

Abstract

Rituximab has been widely used off-label as a second line treatment for children with immune thrombocytopenia (ITP). However, its role in the management of pediatric ITP requires clarification. To understand and interpret the available evidence, we conducted a systematic review to assess the efficacy and safety of rituximab for children with ITP.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
India 1 <1%
Germany 1 <1%
Unknown 118 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 17%
Student > Master 19 16%
Researcher 17 14%
Other 11 9%
Student > Ph. D. Student 11 9%
Other 25 21%
Unknown 18 15%
Readers by discipline Count As %
Medicine and Dentistry 71 59%
Agricultural and Biological Sciences 8 7%
Biochemistry, Genetics and Molecular Biology 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Business, Management and Accounting 2 2%
Other 8 7%
Unknown 22 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2022.
All research outputs
#4,647,314
of 23,317,888 outputs
Outputs from PLOS ONE
#66,079
of 199,314 outputs
Outputs of similar age
#31,579
of 166,389 outputs
Outputs of similar age from PLOS ONE
#875
of 3,754 outputs
Altmetric has tracked 23,317,888 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 199,314 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.3. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,389 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 3,754 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.